Drugs Brain and Behavior (DDP)

• Status: Recruiting
• Trial end date: 2024-01-01
• Target enrollment: 0
• Participant gender: All

Summary

In this project, we will examine individual differences in the effects of a stimulant drug, methamphetamine (MA), on mesolimbic reward function using fMRI.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Chicago
• Treatments: Methamphetamine

Criteria

Inclusion Criteria:

• BMI between 19 and 26

• Right Handed

• Less than 4 alcohol or caffeinated beverages a day.

Exclusion Criteria:

• High blood pressure

• Any medical condition requiring regular medication

• Individuals with a current (within the last year) DSM-IV Axis 1 diagnosis

• Individuals with a history of dependence on stimulant drugs

• Women who are pregnant or trying to become pregnant.